{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:10:56Z","timestamp":1792174256409,"version":"4.4.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/jcp.0b013e318248b7bb","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T09:40:25Z","timestamp":1330076425000},"page":"179-185","source":"Crossref","is-referenced-by-count":105,"title":["Eicosapentaenoic Acid Interventions in Schizophrenia"],"prefix":"10.1097","volume":"32","author":[{"given":"Paolo","family":"Fusar-Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.plipres.2004.05.004","article-title":"Omega-3 fatty acids in cellular membranes: a unified concept.","volume":"43","author":"Valentine","year":"2004","journal-title":"Prog Lipid Res"},{"issue":"2","key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pnpbp.2006.11.013","article-title":"The n-3 polyunsaturated fatty aciddopamine hypothesis of schizophrenia.","volume":"31","author":"Ohara","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mnfr.200900201","article-title":"Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function.","volume":"54","author":"Heinrichs","year":"2010","journal-title":"Mol Nutr Food Res"},{"issue":"2-3","key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12035-010-8139-z","article-title":"Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease.","volume":"41","author":"Palacios-Pelaez","year":"2010","journal-title":"Mol Neurobiol"},{"issue":"3","key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia.","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr Res"},{"issue":"3","key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr Res"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0074-7742(04)59010-4","article-title":"Prostaglandin-mediated signaling in schizophrenia.","volume":"59","author":"Smesny","year":"2004","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline.","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophr Bull"},{"issue":"6","key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.plefa.2003.08.011","article-title":"Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.","volume":"69","author":"Reddy","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"22","key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.2174\/138161209788957438","article-title":"Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.","volume":"15","author":"Stone","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"6","key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001819","article-title":"The role of phospholipases A2 in schizophrenia.","volume":"11","author":"Law","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"2","key":"R22-4-20210128","first-page":"79","article-title":"Incipient neurovulnerability and neuroprotection in early psychosis.","volume":"37","author":"Berger","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":". Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"R30-4-20210128","first-page":"157","article-title":"A fail-safe N for effect size in meta-analysis.","volume":"8","author":"Orwin","year":"1983","journal-title":"J Edu Stat"},{"issue":"1","key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms.","volume":"36","author":"Peet","year":"2002","journal-title":"J Psychiatr Res"},{"issue":"11","key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"1-3","key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.08.011","article-title":"Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D.","volume":"89","author":"Thomas","year":"2007","journal-title":"Schizophr Res"},{"issue":"3-4","key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12640-010-9191-1","article-title":"Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence.","volume":"18","author":"Pukrop","year":"2010","journal-title":"Neurotox Res"},{"issue":"9","key":"R53-4-20210128","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archgenpsychiatry.2011.46","article-title":". Thalamic glutamate levels predicts cortical response during executive functioning in subjects at high risk for psychosis.","volume":"68","author":"Fusar-Poli","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"R54-4-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.eurpsy.2008.03.008","article-title":"Neuroimaging studies of the early stages of psychosis: a critical review.","volume":"23","author":"Fusar-Poli","year":"2008","journal-title":"Eur Psychiatry"},{"issue":"5518","key":"R59-4-20210128","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1126\/science.1059162","article-title":"Control of glutamate clearance and synaptic efficacy by glial coverage of neurons.","volume":"292","author":"Oliet","year":"2001","journal-title":"Science"},{"key":"R61-4-20210128","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Appel for the nutrition committee fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"issue":"1-3","key":"R63-4-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2007.05.036","article-title":"Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients.","volume":"95","author":"Saddichha","year":"2007","journal-title":"Schizophr Res"},{"issue":"6","key":"R64-4-20210128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/YCO.0b013e32833f46c9","article-title":"Cardiovascular aspects of antipsychotics.","volume":"23","author":"Raedler","year":"2010","journal-title":"Curr Opin Psychiatry"},{"issue":"7","key":"R65-4-20210128","first-page":"629","article-title":"Metabolic syndrome in drug-naive first-episode psychosis treated with atypical antipsychotics.","volume":"41","author":"Sahoo","year":"2007","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"R66-4-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","article-title":"Metabolic syndrome with the atypical antipsychotics.","volume":"17","author":"Pramyothin","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"R68-4-20210128","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.clnu.2004.08.001","article-title":"Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects.","volume":"23","author":"Colussi","year":"2004","journal-title":"Clin Nutr"},{"issue":"2","key":"R73-4-20210128","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4088\/JCP.11ac06830","article-title":"Omega-3 fatty acids and depression: from cellular mechanisms to clinical care.","volume":"72","author":"Freeman","year":"2011","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201204000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:17:37Z","timestamp":1618035457000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201204000-00004"}},"subtitle":["Meta-Analysis of Randomized, Placebo-Controlled Studies"],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318248b7bb","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}